This article, published by Consulting.ca, discusses results from Buck’s 2019 Canadian Health Trend Survey, which showed that insurance providers’ pharmaceutical trend factor increases were significantly higher than increases in actual drug costs.
Related insights
Case study: Specialty Drug Claim Review
Concerned about spiraling specialty drug costs, a major pharmaceutical company asked Buck’s Pharmacy team to...
Read moreArticle: Business and HR leaders face COVID-19 vaccine dilemmas
Can businesses mandate their employees to take vaccines before abandoning Zoom and returning to...
Read morePodcast: Talking tomorrow, today
Launched in January 2021, this podcast series delves into a range of topical issues...
Read more